IN SITU ENGINEERING OF ONCOBACTERIA TO REMODEL THE COLORECTAL CANCER MICROENVIRONMENT

$436,398FY2025Defense Health AgencyDOD

Eligo Bioscience

Investigators

View source on USAspending →